Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.81 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.71 |
| ▸ | LPAR4 | Q99677 | 4/20 | 0.71 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.71 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.71 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.71 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.71 |
| ▸ | CES2 | O00748 | 1/20 | 0.71 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.71 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.71 |
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.64 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.64 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.64 |
| ▸ | PRKCA | P17252 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Monoolein SCHEMBL18623398 | 1.00 | DGKA (0.81) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL18623412 | 1.00 | DGKA (0.81) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL18623397 | 1.00 | DGKA (0.81) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL19821305 | 1.00 | DGKA (0.81) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL28064656 | 0.96 | FAAH (0.76) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL11782255 | 0.94 | DGKA (0.86) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL2733309 | 0.94 | DGKA (0.86) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL18197507 | 0.94 | DGKA (0.86) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL17099733 | 0.94 | DGKA (0.86) | DGKALPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL5944443 | 0.94 | DGKA (0.86) | DGKALPAR1LPAR4LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4531812-A1 | LIPID NANOCARRIER VACCINE | Royal Melbourne Institute of Technology (AU) | 2025-04-09 | — | — | EP | claimed |
| EP-4302096-A1 | METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA | APHP (Assistance Publique - Hôpitaux de Paris) (FR) | 2024-01-10 | — | — | EP | claimed |
| WO-2023225722-A1 | LIPID NANOCARRIER VACCINE | ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY (AU) | 2023-11-30 | — | — | WO | claimed |
| WO-2022184856-A1 | METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA | APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) (FR) | 2022-09-09 | — | — | WO | claimed |
| EP-1940347-B2 | FATTY ACID ESTERS FOR REDUCING THE STICKINESS OF STYLING COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2021-07-14 | — | — | EP | claimed |
| EP-1940347-B1 | FATTY ACID ESTERS FOR REDUCING THE STICKINESS OF STYLING COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2013-10-09 | — | — | EP | claimed |
| EP-4531812-A1 | LIPID NANOCARRIER VACCINE | Royal Melbourne Institute of Technology (AU) | 2025-04-09 | — | — | EP | disclosed |
| EP-4511065-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | Royal Melbourne Institute of Technology (AU) | 2025-02-26 | — | — | EP | disclosed |
| US-12214105-B2 | Long lasting biodegradable polymer based in-situ forming implant for treatment of bone injuries | FUTURE UNIVERSITY IN EGYPT (EG) | 2025-02-04 | — | — | US | disclosed |
| EP-4427596-A2 | FOODSTUFFS AND METHODS FOR MAKING THE SAME | Planted Foods AG (CH) | 2024-09-11 | — | — | EP | disclosed |
| US-20240268407-A1 | FOODSTUFFS AND METHODS FOR MAKING THE SAME | PLANTED FOODS AG (CH) | 2024-08-15 | — | — | US | disclosed |
| EP-4388116-A1 | FAT-LIKE COMPOSITIONS AND METHODS FOR MAKING THE SAME | Planted Foods AG (CH) | 2024-06-26 | — | — | EP | disclosed |
| EP-4302096-A1 | METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA | APHP (Assistance Publique - Hôpitaux de Paris) (FR) | 2024-01-10 | — | — | EP | disclosed |
| US-9957215-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170332650-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | APEEL TECHNOLOGY, INC. | 2017-11-23 | — | — | US | disclosed |
| US-20170073532-A1 | Precursor compounds for molecular coatings | APEEL TECHNOLOGY, INC. | 2017-03-16 | — | — | US | disclosed |
| US-9282737-B2 | Agent for preventing pollen dispersal | NOF CORPORATION (JP) | 2016-03-15 | — | — | US | disclosed |
| EP-2245933-B1 | AGENT FOR PREVENTING POLLEN DISPERSAL | NOF CORP (JP) | 2015-12-16 | — | — | EP | disclosed |
| US-20110045981-A1 | AGENT FOR PREVENTING POLLEN DISPERSAL | NOF CORPORATION (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2245933-A1 | AGENT FOR PREVENTING POLLEN DISPERSAL | NOF Corporation (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110045981-A1 | AGENT FOR PREVENTING POLLEN DISPERSAL | ALOX5, PLD1, ALOX15B | DGKA 93/4885LPAR1 18/4885LPAR4 48/4885 |
| US-20170332650-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | TET2, SI, CAT | DGKA 1845/4885LPAR1 4426/4885LPAR4 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.